Skip to main content
Advertisement
Advertisement

ALKS

ALKS logo

Alkermes Inc. plc

41.22
USD
Sponsored
+1.12
+2.79%
Oct 16, 15:59 UTC -4
Closed
exchange

After-Market

41.16

-0.06
-0.15%

ALKS Earnings Reports

Positive Surprise Ratio

ALKS beat 34 of 43 last estimates.

79%

Next Report

Date of Next Report
Oct 28, 2026
Estimate for Q3 26 (Revenue/ EPS)
$472.43M
/
-$0.06
Implied change from Q2 26 (Revenue/ EPS)
-4.75%
/
--
Implied change from Q3 25 (Revenue/ EPS)
+19.85%
/
-112.24%

Alkermes Inc. plc earnings per share and revenue

On Jul 28, 2026, ALKS reported earnings of 0.00 USD per share (EPS) for Q2 26, beating the estimate of -0.02 USD, resulting in a 100.00% surprise. Revenue reached 496.01 million, compared to an expected 466.97 million, with a 6.22% difference. The market reacted with a -4.23% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 9 analysts forecast an EPS of -0.06 USD, with revenue projected to reach 472.43 million USD, implying an -- of --% EPS, and decrease of -4.75% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Oct 12, 2026 For Q3 26
Estimate
-$0.61
Actual
$4.73
Surprise
+871.74%
FAQ
For Q2 2026, Alkermes Inc. plc reported EPS of $0.00, beating estimates by 100%, and revenue of $496.01M, 6.22% above expectations.
The stock price moved down -4.23%, changed from $52.73 before the earnings release to $50.50 the day after.
The next earning report is scheduled for Oct 28, 2026.
Based on 9 analysts, Alkermes Inc. plc is expected to report EPS of -$0.06 and revenue of $472.43M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement